PlumX Metrics
Embed PlumX Metrics

The transcriptomic response of cells to a drug combination is more than the sum of the responses to the monotherapies

eLife, ISSN: 2050-084X, Vol: 9, Page: 1-62
2020
  • 19
    Citations
  • 0
    Usage
  • 101
    Captures
  • 1
    Mentions
  • 89
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    19
  • Captures
    101
  • Mentions
    1
    • News Mentions
      1
      • 1
  • Social Media
    89
    • Shares, Likes & Comments
      89
      • Facebook
        89

Most Recent News

Fighting COVID-19 with the Synergistic Rhythms of the Tango

Anyone can publish on Medium per our Policies , but we don’t fact-check every story. For more info about the coronavirus, see cdc.gov . 2

Article Description

Our ability to discover effective drug combinations is limited, in part by insufficient understanding of how the transcriptional response of two monotherapies results in that of their combination. We analyzed matched time course RNAseq profiling of cells treated with single drugs and their combinations and found that the transcriptional signature of the synergistic combination was unique relative to that of either constituent monotherapy. The sequential activation of transcription factors in time in the gene regulatory network was implicated. The nature of this transcriptional cascade suggests that drug synergy may ensue when the transcriptional responses elicited by two unrelated individual drugs are correlated. We used these results as the basis of a simple prediction algorithm attaining an AUROC of 0.77 in the prediction of synergistic drug combinations in an independent dataset.

Bibliographic Details

Diaz, Jennifer El; Ahsen, Mehmet Eren; Schaffter, Thomas; Chen, Xintong; Realubit, Ronald B; Karan, Charles; Califano, Andrea; Losic, Bojan; Stolovitzky, Gustavo

eLife Sciences Publications, Ltd

Neuroscience; Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know